The Biggest Shortcoming With Glide-Paths In Target-Date Funds

Ben Inker (GMO) explains how valuation should be a key driver of how an investor’s asset allocation looks at a given life stage. (Video length 00:09:49)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.